3.3 Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Miscellaneous OTC Analgesics

Nonsteroidal anti-inflammatory drugs (NSAIDs) and over-the-counter (OTC) combination analgesics account for tens of thousands of poison center consultations annually. While the vast majority of pediatric exploratory ingestions run a benign, self-limited clinical course, massive ingestions or specific high-risk chemical entities produce life-threatening neurological, hematological, and renal catastrophes. Poison information specialists must accurately calculate weight-based thresholds, anticipate agent-specific complications, and deconstruct multi-ingredient formulations.

---

NSAID Classification and Cyclooxygenase Inhibition

NSAIDs encompass a structurally diverse group of organic acids that share a common pharmacologic mechanism: the reversible inhibition of cyclooxygenase (COX) isoenzymes (prostaglandin-endoperoxide synthase 1 and 2):

• COX-1 (Constitutive): Expressed constitutively in gastric mucosa, platelets, vascular endothelium, and renal parenchyma. It catalyzes the synthesis of prostaglandins that maintain gastric mucosal blood flow, stimulate protective bicarbonate and mucus secretion, and produce thromboxane A2 to support platelet aggregation.
• COX-2 (Inducible & Constitutive): Primarily induced in endothelial cells, macrophages, and synovial fibroblasts during inflammatory cascades. Crucially, COX-2 is also constitutively expressed in the kidneys, central nervous system, and vascular endothelium, playing an essential role in salt and water homeostasis and renal vasodilation.

Major Chemical Classes of NSAIDs

1. Propionic Acid Derivatives: Ibuprofen, naproxen, ketoprofen, flurbiprofen, oxaprozin. (Most common OTC exposures).
2. Acetic Acid Derivatives: Indomethacin, sulindac, diclofenac, ketorolac, etodolac.
3. Enolic Acid (Oxicam) Derivatives: Meloxicam, piroxicam. (Characterized by exceptionally long elimination half-lives and extensive enterohepatic recirculation).
4. Anthranilic Acid (Fenamate) Derivatives: Mefenamic acid, meclofenamate. (Possess distinct neurotoxic epileptogenic potential).
5. Selective COX-2 Inhibitors: Celecoxib.

---

Renal Hemodynamics and Nephrotoxicity

Under normal physiological resting conditions, renal blood flow is regulated by systemic hemodynamics. However, in states of physiological stress, hypovolemia, effective arterial volume depletion, or toxic overdose, circulating vasoconstrictors (angiotensin II, endothelin, vasopressin, and norepinephrine) constrict renal arterioles to preserve systemic blood pressure.

The Prostaglandin Compensatory Shield

To safeguard glomerular filtration from excessive ischemic constriction, the kidney synthesizes local vasodilatory prostaglandins (principally PGE2 and PGI2/prostacyclin) at the afferent arteriole:

• These prostaglandins act locally to produce compensatory afferent arteriolar vasodilation.
• This counter-regulatory dilation maintains glomerular capillary hydrostatic pressure and preserves glomerular filtration rate (GFR).

The Mechanism of NSAID-Induced Acute Kidney Injury

When toxic doses of NSAIDs inhibit COX-1 and COX-2:

1. Renal synthesis of PGE2 and PGI2 is abruptly terminated.
2. Without counter-regulatory prostaglandin vasodilation, vasoconstriction mediated by angiotensin II and norepinephrine proceeds unopposed at the afferent arteriole.
3. Glomerular capillary blood flow and hydrostatic pressure collapse, producing an acute, severe drop in GFR (prerenal azotemia).
4. Prolonged, profound renal medullary ischemia can advance rapidly to acute tubular necrosis (ATN).
5. Concurrently, immune-mediated responses can induce acute interstitial nephritis (AIN) characterized by eosinophil infiltration, pyuria, and azotemia.

Ibuprofen Dose-Dependent Toxicity and Triage Thresholds

Ibuprofen serves as the universal benchmark for pediatric and adult NSAID risk assessment. The clinical trajectory correlates tightly with the ingested dose expressed in milligrams per kilogram (mg/kg):

These cutoffs come from the classic ibuprofen overdose series (Hall and colleagues); individual poison center protocols vary, and some centers observe asymptomatic, unintentional pediatric ingestions at home up to about 200 mg/kg. Know your center guideline, but expect CSPI items to use the 100 mg/kg and 400 mg/kg anchors.

Critical Triage Rules for Poison Information Specialists

1. Intentional Ingestions: Any self-harm attempt or intentional ingestion must be referred to a healthcare facility immediately, regardless of the reported dose.
2. Symptomatic Patients: Any patient experiencing symptoms beyond mild, transient nausea (e.g., persistent vomiting, significant drowsiness, abdominal tenderness) must be referred to an emergency department regardless of the calculated dose.
3. Underlying Vulnerability: Patients with pre-existing chronic kidney disease, volume depletion, heart failure, cirrhosis, or concomitant therapy with ACE inhibitors, ARBs, or diuretics have an impaired compensatory margin and require clinical evaluation at lower thresholds (e.g., > 50 mg/kg).
4. Liquid Formulations: Chewables and concentrated liquid infant drops (50 mg/1.25 mL) carry high risk for dosing miscalculations; calculate total milligrams ingested based strictly on bottle concentration and volume missing.

---

High-Risk and Atypical NSAIDs: Mefenamic Acid and Oxicams

While most NSAIDs produce predictable dose-dependent gastrointestinal and renal toxicity, two drug classes possess unique, perilous clinical profiles:

1. Mefenamic Acid: The Epileptogenic NSAID

Mefenamic acid (Ponstel), an anthranilic acid derivative commonly prescribed for dysmenorrhea and short-term pain, possesses an idiosyncratic central neurotoxicity distinct from all other NSAIDs:

• High Risk of Generalized Seizures: Seizures are a recognized feature of mefenamic acid overdose even though the precise neuroexcitatory mechanism is not established.
• Clinical Presentation: Overdoses of only a few grams in adults have been followed by sudden, unprovoked generalized tonic-clonic seizures. Seizures characteristically emerge rapidly (within 2 to 7 hours post-ingestion) and frequently develop without any preceding gastrointestinal symptoms or warning signs.
• Management: First-line seizure control requires intravenous benzodiazepines (lorazepam or diazepam). All intentional or supratherapeutic mefenamic acid ingestions must be evaluated in an emergency department with continuous cardiac and neurological monitoring for a minimum of 6 to 8 hours.

2. Meloxicam and Piroxicam: The Long-Acting Oxicams

Enolic acid derivatives (oxicams) exhibit extraordinarily prolonged elimination half-lives (meloxicam half-life is 15 to 20 hours; piroxicam half-life is 30 to 50 hours). They undergo extensive enterohepatic recirculation, continually recycling from the biliary tract back into systemic circulation. In overdose:

• Toxicity is protracted, with renal failure and gastric mucosal ulceration manifesting 24 to 72 hours post-ingestion.
• Enhanced Elimination with Cholestyramine: Oral administration of cholestyramine (4 grams orally every 6 hours) or activated charcoal binds oxicams within the intestinal lumen, interrupting enterohepatic cycling and accelerating elimination clearance by up to 50%.

Phenazopyridine Toxicology: Methemoglobinemia and Hemolysis

Phenazopyridine (Pyridium, Azo-Standard) is an azo dye utilized as an over-the-counter and prescription urinary tract analgesic. In overdose (> 20 to 30 mg/kg acute ingestion, or cumulative supratherapeutic dosing in patients with underlying renal insufficiency), its active metabolites produce profound oxidative erythrocyte stress:

1. Methemoglobinemia

Phenazopyridine metabolites oxidize the iron atom in hemoglobin from the normal ferrous state (Fe2+) to the ferric state (Fe3+), forming methemoglobin:

• Ferric hemoglobin cannot bind oxygen.
• Furthermore, the presence of ferric heme produces an allosteric shift in the remaining ferrous hemes, locking them into an ultra-high affinity state (shifting the oxygen-hemoglobin dissociation curve sharply to the left). This prevents oxygen release to peripheral tissues, causing severe tissue hypoxia.
• Diagnostic Hallmarks:
  • Slate-gray cyanosis refractory to 100% supplemental oxygen
  • Standard pulse oximetry readings fixed at 82% to 85% (due to methemoglobin's equal light absorption at 660 nm and 940 nm wavelengths)
  • Normal arterial blood gas PaO2 (dissolved plasma oxygen is normal, but oxygen-carrying capacity is crippled)
  • Dark chocolate-brown or muddy venous blood that fails to turn bright red upon exposure to ambient air
• Antidotal Therapy: Administer intravenous methylene blue (1 to 2 mg/kg IV over 5 minutes) for methemoglobin levels greater than 20% to 30%, or lower if symptomatic with dyspnea, altered mental status, or cardiac ischemia. (Methylene blue is reduced by NADPH–methemoglobin reductase to leukomethylene blue, which then reduces methemoglobin back to hemoglobin.)

2. Heinz-Body Hemolytic Anemia

Severe oxidative stress denatures hemoglobin tetramers, forming microscopic intracellular precipitates known as Heinz bodies. As red cells traverse splenic cords, macrophages extract these rigid inclusions, forming "bite cells" and causing severe extravascular and intravascular hemolytic anemia.

Critical Warning regarding G6PD Deficiency: Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency cannot generate sufficient NADPH. In G6PD-deficient individuals, phenazopyridine induces catastrophic hemolysis, and methylene blue is ineffective and contraindicated (it requires NADPH to be converted to leukomethylene blue, and methylene blue itself acts as an oxidant in G6PD deficiency). Severe cases require exchange transfusion or hyperbaric oxygen.

3. Benign Chromaturia

Phenazopyridine imparts an intense, vivid orange-to-red discoloration to urine, tears, and soft contact lenses. Callers must be reassured that orange urine is a harmless pharmacological dye effect, but cautioned against wearing soft contact lenses, which will be permanently stained.

4. Other Genitourinary Agents on the Topic List

---

Combination OTC Analgesics: Navigating Complex Formulations (Excedrin Triage)

One of the most dangerous triage traps encountered by poison specialists involves over-the-counter multi-ingredient analgesics, exemplified by Excedrin Extra Strength and Excedrin Migraine.

Standard Formulation Breakdown (Per Caplet/Tablet):

• Acetaminophen (APAP): 250 mg
• Aspirin (ASA): 250 mg
• Caffeine: 65 mg

The Triple-Triage Mandate

When a caller reports ingesting "a bottle of Excedrin" (e.g., 60 caplets), the specialist cannot treat the exposure as a single drug ingestion. The specialist must execute a simultaneous, triple-agent clinical calculation:

1. Acetaminophen Assessment: 60 caplets × 250 mg = 15,000 mg (15 g) APAP. Draw a serum APAP concentration at 4 hours post-ingestion and plot on the Rumack-Matthew nomogram; initiate full NAC therapy if indicated.
2. Aspirin Assessment: 60 caplets × 250 mg = 15,000 mg (15 g) Salicylate. In a 70-kg adult, this equals ~214 mg/kg (moderate toxicity range). Order serial salicylate levels every 2 hours, monitor venous blood gases, and prepare for sodium bicarbonate urinary alkalinization.
3. Caffeine Toxicity Assessment: 60 caplets × 65 mg = 3,900 mg (3.9 g) Caffeine. Supratherapeutic caffeine ingestion produces:
   • Competitive antagonism of central adenosine receptors, driving severe sympathetic outflow
   • Non-selective phosphodiesterase (PDE) inhibition, elevating intracellular cyclic AMP (cAMP)
   • Massive catecholamine surges causing sinus tachycardia, supraventricular tachycardias, ventricular dysrhythmias (PVCs, VTach), intractable vomiting, hypokalemia (intracellular potassium shifts driven by beta-2 adrenergic stimulation), hypophosphatemia, tremor, and refractory seizures.
   • Treatment: Judicious use of short-acting beta-blockers (e.g., IV esmolol) for severe tachydysrhythmias, aggressive potassium replacement, and IV benzodiazepines for agitation and seizures.

---

Emergency Department Supportive Protocols and Enhanced Elimination Inutility

1. Gastrointestinal Decontamination:
   • Single-dose activated charcoal (1 g/kg, up to 50 g) is recommended only if the patient presents within 1 to 2 hours of a significant toxic ingestion (> 100 to 400 mg/kg) and has an intact, protected airway.
   • Because liquid gels and pediatric suspensions are absorbed rapidly from the upper duodenum, the utility of activated charcoal drops precipitously beyond 60 to 90 minutes.
2. Enhanced Elimination Limitations:
   • Virtually all NSAIDs exhibit extremely high plasma protein binding (> 95% to 99% bound to albumin) and moderate volumes of distribution.
   • Consequently, hemodialysis, hemoperfusion, and forced diuresis are ineffective at removing circulating ibuprofen, naproxen, meloxicam, or celecoxib.
   • Hemodialysis is utilized strictly as a supportive therapy for standard renal indications: refractory hyperkalemia, severe unresponsive metabolic acidosis, uremic pericarditis/encephalopathy, or intractable volume overload resulting from acute tubular necrosis.
3. Supportive Care Protocol:
   • Intravenous Fluid Resuscitation: Administer isotonic crystalloids (normal saline or lactated Ringer's) at 1 to 2 times maintenance to maintain brisk renal perfusion and target urine output at 1 to 2 mL/kg/hour in children and 50 to 100 mL/hour in adults.
   • Gastroprotection: Administer intravenous proton pump inhibitors (e.g., pantoprazole 40 mg IV) or H2-receptor antagonists for patients presenting with dyspepsia, hematemesis, or significant abdominal pain.
   • Laboratory Monitoring: Obtain a baseline basic metabolic panel (BUN, creatinine, electrolytes) and repeat at 4 to 6 hours post-ingestion. If renal function and electrolytes remain entirely normal at 6 hours post-ingestion and the patient is asymptomatic, medical clearance for discharge may be granted.